Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation - Stock Option Activity (Details)

v3.21.2
Stock-Based Compensation - Stock Option Activity (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 9 Months Ended 12 Months Ended
Oct. 31, 2021
Jan. 31, 2021
Number of stock options outstanding    
Beginning balance (in shares) 46,455  
Granted (in shares) 10,641  
Exercised (in shares) (8,882)  
Cancelled/forfeited (in shares) (2,447)  
Ending balance (in shares) 45,767 46,455
Exercisable (in shares) 16,433  
Vested and expected to vest (in shares) 37,577  
Weighted average exercise price    
Beginning balance, weighted average exercise price (in dollars per share) $ 4.37  
Granted, weighted average exercise price (in dollars per share) 11.43  
Exercised, weighted average exercise price (in dollars per share) 2.02  
Cancelled/forfeited, weighted average exercise price (in dollars per share) 8.34  
Ending balance, weighted average exercise price (in dollars per share) 6.25 $ 4.37
Exercisable, weighted average exercise price (in dollars per share) 4.28  
Vested and expected to vest, weighted average exercise price (in dollars per share) $ 5.76  
Weighted average remaining contractual life 8 years 7 years 8 months 12 days
Exercisable, weighted average remaining contractual term 7 years 1 month 6 days  
Vested and expected to vest, weighted average remaining contractual term 7 years 9 months 18 days  
Aggregate intrinsic value $ 597,167 $ 218,450
Exercisable, aggregate intrinsic value 246,801  
Vested and expected to vest, aggregate intrinsic value $ 508,972